Dyne Therapeutics shareholders elect three Class I directors, ratify Deloitte as auditor

Dyne Therapeutics, Inc.

Carlo Incerti, M.D. elected with 61,028,245 votes for, 8,752,856 withheld, 5,235,919 broker non-votes.
Catherine Stehman-Breen, M.D. elected with 55,026,485 votes for, 14,325,362 withheld, 5,665,173 broker non-votes.
John G. Cox elected with 69,763,860 votes for, 32,767 withheld, 5,220,393 broker non-votes.
Ratification of Deloitte & Touche as independent auditor for FY2024 passed with 74,962,217 for, 12,377 against, 42,426 abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.